Form 4: Theravance Biopharma Executive Rhonda Farnum Reports Stock Transaction
SEC Form 4 Filing
Rhonda Farnum, SVP at Theravance Biopharma, reports disposition of shares to cover tax obligations.
Summary
- On August 20, 2024, Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc. (TBPH), disposed of 9,222 ordinary shares.
- The shares were withheld to satisfy tax obligations arising from the vesting of previously granted restricted stock units.
- The transaction price was $8.22 per share.
- Following the transaction, Farnum beneficially owns 326,743 ordinary shares.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of a stock transaction related to tax obligations, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions, which can be informative but don't necessarily indicate a change in the company's overall prospects.
Key Dates
| Date | Description |
|---|---|
| 08/20/2024 | Date of stock transaction (disposal of shares). |
| 08/22/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.